• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆纤维连接蛋白缺乏会阻碍动脉粥样硬化进展和纤维帽形成。

Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation.

机构信息

Department for Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried, Germany.

出版信息

EMBO Mol Med. 2012 Jul;4(7):564-76. doi: 10.1002/emmm.201200237. Epub 2012 Apr 19.

DOI:10.1002/emmm.201200237
PMID:22514136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3407945/
Abstract

Atherosclerotic lesions are asymmetric focal thickenings of the intima of arteries that consist of lipids, various cell types and extracellular matrix (ECM). These lesions lead to vascular occlusion representing the most common cause of death in the Western world. The main cause of vascular occlusion is rupture of atheromatous lesions followed by thrombus formation. Fibronectin (FN) is one of the earliest ECM proteins deposited at atherosclerosis-prone sites and was suggested to promote atherosclerotic lesion formation. Here, we report that atherosclerosis-prone apolipoprotein E-null mice lacking hepatocyte-derived plasma FN (pFN) fed with a pro-atherogenic diet display dramatically reduced FN depositions at atherosclerosis-prone areas, which results in significantly smaller and fewer atherosclerotic plaques. However, the atherosclerotic lesions from pFN-deficient mice lacked vascular smooth muscle cells and failed to develop a fibrous cap. Thus, our results demonstrate that while FN worsens the course of atherosclerosis by increasing the atherogenic plaque area, it promotes the formation of the protective fibrous cap, which in humans prevents plaques rupture and vascular occlusion.

摘要

动脉粥样硬化病变是动脉内膜的非对称局灶性增厚,由脂质、各种细胞类型和细胞外基质 (ECM) 组成。这些病变导致血管阻塞,是西方世界最常见的死亡原因。血管阻塞的主要原因是动脉粥样硬化病变破裂,随后形成血栓。纤连蛋白 (FN) 是最早沉积在易发生动脉粥样硬化部位的 ECM 蛋白之一,被认为可促进动脉粥样硬化病变的形成。在这里,我们报告载脂蛋白 E 基因敲除小鼠缺乏肝细胞衍生的血浆 FN (pFN),易发生动脉粥样硬化,喂食致动脉粥样硬化饮食后,易发生动脉粥样硬化部位的 FN 沉积明显减少,导致动脉粥样硬化斑块明显变小、数量减少。然而,pFN 缺陷小鼠的动脉粥样硬化病变缺乏血管平滑肌细胞,无法形成纤维帽。因此,我们的结果表明,尽管 FN 通过增加致动脉粥样硬化斑块面积使动脉粥样硬化恶化,但它促进了保护性纤维帽的形成,在人类中,纤维帽可防止斑块破裂和血管阻塞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/a719a9736c96/emmm0004-0564-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/beea8c8d9fb8/emmm0004-0564-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/899ea9f073bf/emmm0004-0564-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/f82701094bb9/emmm0004-0564-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/dc0d8303dc42/emmm0004-0564-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/126284299b66/emmm0004-0564-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/2006a328f85e/emmm0004-0564-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/a719a9736c96/emmm0004-0564-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/beea8c8d9fb8/emmm0004-0564-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/899ea9f073bf/emmm0004-0564-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/f82701094bb9/emmm0004-0564-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/dc0d8303dc42/emmm0004-0564-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/126284299b66/emmm0004-0564-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/2006a328f85e/emmm0004-0564-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe42/3407945/a719a9736c96/emmm0004-0564-f7.jpg

相似文献

1
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation.血浆纤维连接蛋白缺乏会阻碍动脉粥样硬化进展和纤维帽形成。
EMBO Mol Med. 2012 Jul;4(7):564-76. doi: 10.1002/emmm.201200237. Epub 2012 Apr 19.
2
Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.含额外结构域 A 的纤连蛋白导致载脂蛋白 E 缺陷型高龄小鼠无名动脉斑块不稳定。
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):500-508. doi: 10.1161/ATVBAHA.117.310345. Epub 2018 Jan 11.
3
Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.内皮细胞特异性缺失P2Y2受体可促进动脉粥样硬化易感载脂蛋白E基因敲除小鼠的斑块稳定性。
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):75-83. doi: 10.1161/ATVBAHA.116.308561. Epub 2016 Nov 17.
4
Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.含额外结构域 A 的纤连蛋白剪接变体通过 Toll 样受体 4 促进小鼠动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2391-400. doi: 10.1161/ATVBAHA.115.306474. Epub 2015 Oct 1.
5
Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.内皮细胞衍生的血管生成素样蛋白 2 在血管炎症导致内皮功能障碍和动脉粥样硬化进展中的作用。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):790-800. doi: 10.1161/ATVBAHA.113.303116. Epub 2014 Feb 13.
6
Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.强效血管收缩剂亲吻素-10诱导动脉粥样硬化斑块进展和不稳定:其受体GPR54拮抗剂可逆转
J Am Heart Assoc. 2017 Apr 14;6(4):e005790. doi: 10.1161/JAHA.117.005790.
7
Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis.抑制整合素 α5 胞质结构域信号转导可减少动脉粥样硬化并促进动脉生成。
J Am Heart Assoc. 2018 Jan 30;7(3):e007501. doi: 10.1161/JAHA.117.007501.
8
Effect of Tie-2 conditional deletion of BDNF on atherosclerosis in the ApoE null mutant mouse.BDNF的Tie-2条件性缺失对ApoE基因敲除突变小鼠动脉粥样硬化的影响。
Biochim Biophys Acta. 2012 Jun;1822(6):927-35. doi: 10.1016/j.bbadis.2012.02.014. Epub 2012 Feb 22.
9
Effects of the factor Xa inhibitor, fondaparinux, on the stability of atherosclerotic lesions in apolipoprotein E-deficient mice.凝血因子Xa抑制剂磺达肝癸钠对载脂蛋白E缺乏小鼠动脉粥样硬化病变稳定性的影响。
Circ J. 2015;79(11):2499-508. doi: 10.1253/circj.CJ-15-0285. Epub 2015 Sep 3.
10
Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.C5ar2缺乏在载脂蛋白E缺乏小鼠中的抗动脉粥样硬化作用。
Thromb Haemost. 2015 Oct;114(4):848-58. doi: 10.1160/TH14-12-1075. Epub 2015 Jun 18.

引用本文的文献

1
Identification of Potential Therapeutic Targets for Coronary Atherosclerosis from an Inflammatory Perspective Through Integrated Proteomics and Single-Cell Omics.通过整合蛋白质组学和单细胞组学从炎症角度鉴定冠状动脉粥样硬化的潜在治疗靶点
Int J Mol Sci. 2025 Jun 27;26(13):6201. doi: 10.3390/ijms26136201.
2
Smooth Muscle Cell-Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO-cGMP Signaling.平滑肌细胞衍生的纤连蛋白促进与一氧化氮-环磷酸鸟苷信号改变相关的抗动脉粥样硬化平滑肌细胞表型。
J Am Heart Assoc. 2025 Jun 3;14(11):e040395. doi: 10.1161/JAHA.124.040395. Epub 2025 May 29.
3

本文引用的文献

1
Progress and challenges in translating the biology of atherosclerosis.动脉粥样硬化生物学翻译的进展与挑战。
Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146.
2
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.用醛基修饰的纤维连接蛋白免疫载脂蛋白 E 基因敲除小鼠可抑制动脉粥样硬化的发展。
Cardiovasc Res. 2011 Aug 1;91(3):528-36. doi: 10.1093/cvr/cvr101. Epub 2011 Apr 14.
3
Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis.高脂血症触发的中性粒细胞增多促进早期动脉粥样硬化。
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target.
作为治疗靶点的动脉粥样硬化斑块微环境
Curr Atheroscler Rep. 2025 Apr 2;27(1):47. doi: 10.1007/s11883-025-01294-y.
4
Changes in various forms of fibronectin in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass - a prospective, observational study.体外循环下冠状动脉搭桥术患者不同形式纤连蛋白的变化——一项前瞻性观察研究
Sci Rep. 2024 Dec 28;14(1):30790. doi: 10.1038/s41598-024-80765-9.
5
Piezo1-mediated mechanotransduction enhances macrophage oxidized low-density lipoprotein uptake and atherogenesis.Piezo1介导的机械转导增强巨噬细胞对氧化低密度脂蛋白的摄取及动脉粥样硬化的发生。
PNAS Nexus. 2024 Oct 4;3(11):pgae436. doi: 10.1093/pnasnexus/pgae436. eCollection 2024 Nov.
6
Vascular smooth muscle cell phenotypic switching in atherosclerosis.动脉粥样硬化中的血管平滑肌细胞表型转换
Heliyon. 2024 Sep 10;10(18):e37727. doi: 10.1016/j.heliyon.2024.e37727. eCollection 2024 Sep 30.
7
Endothelial Immunosuppression in Atherosclerosis : Translational Control by Elavl1/HuR.动脉粥样硬化中的内皮免疫抑制:Elavl1/HuR的翻译调控
bioRxiv. 2024 Aug 4:2024.08.02.605922. doi: 10.1101/2024.08.02.605922.
8
Mzb1 Attenuates Atherosclerotic Plaque Vulnerability in ApoE-/- Mice by Alleviating Apoptosis and Modulating Mitochondrial Function.Mzb1 通过减轻细胞凋亡和调节线粒体功能来减轻载脂蛋白 E 基因敲除小鼠的动脉粥样硬化斑块易损性。
J Cardiovasc Transl Res. 2024 Aug;17(4):782-794. doi: 10.1007/s12265-024-10483-0. Epub 2024 Jan 31.
9
The role of TNC in atherosclerosis and drug development opportunities.TNC 在动脉粥样硬化中的作用和药物研发机会。
Int J Biol Sci. 2024 Jan 1;20(1):127-136. doi: 10.7150/ijbs.89890. eCollection 2024.
10
Human Plaque Myofibroblasts to Study Mechanisms of Atherosclerosis.人动脉粥样硬化斑块肌成纤维细胞的研究
J Am Heart Assoc. 2023 Nov 7;12(21):e030243. doi: 10.1161/JAHA.123.030243. Epub 2023 Oct 27.
Circulation. 2010 Nov 2;122(18):1837-45. doi: 10.1161/CIRCULATIONAHA.110.961714. Epub 2010 Oct 18.
4
Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.永生 bEnd5 细胞和原代小鼠脑微血管内皮细胞作为研究 T 细胞渗出的体外血脑屏障模型的比较。
J Cereb Blood Flow Metab. 2011 Jan;31(1):315-27. doi: 10.1038/jcbfm.2010.96. Epub 2010 Jul 7.
5
Atheroprone hemodynamics regulate fibronectin deposition to create positive feedback that sustains endothelial inflammation.易损斑块血流动力学调节纤维连接蛋白沉积,形成正反馈,从而维持内皮炎症。
Circ Res. 2010 Jun 11;106(11):1703-11. doi: 10.1161/CIRCRESAHA.109.216283. Epub 2010 Apr 8.
6
Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells.基质特异性蛋白激酶 A 信号转导调节内皮细胞中由流动引起的 p21 激活激酶的激活。
Circ Res. 2010 Apr 30;106(8):1394-403. doi: 10.1161/CIRCRESAHA.109.210286. Epub 2010 Mar 11.
7
Monocytes in atherosclerosis: subsets and functions.动脉粥样硬化中的单核细胞:亚群与功能。
Nat Rev Cardiol. 2010 Feb;7(2):77-86. doi: 10.1038/nrcardio.2009.228. Epub 2010 Jan 12.
8
Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes.易损粥样硬化斑块中的金属蛋白酶和泡沫细胞表型。
Thromb Haemost. 2009 Jun;101(6):1006-11.
9
The subendothelial extracellular matrix modulates JNK activation by flow.内皮下细胞外基质通过血流调节JNK激活。
Circ Res. 2009 Apr 24;104(8):995-1003. doi: 10.1161/CIRCRESAHA.108.186486. Epub 2009 Mar 12.
10
Fibronectins in vascular morphogenesis.血管形态发生中的纤连蛋白。
Angiogenesis. 2009;12(2):165-75. doi: 10.1007/s10456-009-9136-6. Epub 2009 Feb 14.